Where does GiveWell explain the reasoning for discounting the effect of the treatment observed in the data by 87%? Looking at the post you linked I don’t see 87% mentioned, but there is a link to this cost-effectiveness estimate but that ranges from 54% to 85% but those are also from Nov 2016.
Where does GiveWell explain the reasoning for discounting the effect of the treatment observed in the data by 87%? Looking at the post you linked I don’t see 87% mentioned, but there is a link to this cost-effectiveness estimate but that ranges from 54% to 85% but those are also from Nov 2016.
You can find their replicability adjustment here, and explanations are in this doc :)
Thank you!